Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry)

The American Journal of Cardiology
N S KleimanP H Stone

Abstract

The aim of this study was to characterize patients with and without prior coronary artery bypass grafting (CABG) among a prospectively identified cohort of patients presenting with unstable angina or non-Q-wave myocardial infarction. Patients in the Thrombolysis in Myocardial Infarction phase III Registry Prospective Study presented within 96 hours of an episode of unstable angina or non-Q-wave acute myocardial infarction. Of 2,048 patients, 336 (16.4%) had prior CABG. Compared with those without prior CABG, patients were the same age, but were more likely to be men, white, diabetic, have a history of angina or myocardial infarction, to have received anti-ischemic medications in the prior week, and to receive intravenous heparin or nitroglycerin, or both, during hospitalization. They were equally likely to undergo coronary angioplasty or CABG. Death or nonfatal myocardial infarction occurred by day 10 in 4.5% of patients with prior CABG and 2.8% of patients without prior CABG (p = 0.11); and by day 42 in 7.7% and 5.1%, respectively (p = 0.03). The composite of death, myocardial infarction, or recurrent ischemia at 1 year was more common among patients with prior CABG (39.3% vs 30.2%, p = 0.002). By multiple logistic regression,...Continue Reading

Associated Clinical Trials

References

Oct 14, 1992·JAMA : the Journal of the American Medical Association·S B Eysmann, P S Douglas
Sep 1, 1986·The American Journal of Cardiology·D D WatersP Théroux
Dec 1, 1986·American Journal of Public Health·C MaynardT Pullum
Mar 22, 1984·The New England Journal of Medicine·UNKNOWN CASS Principal Investigators and Their Associates

❮ Previous
Next ❯

Citations

Jun 3, 2015·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Nagendra R PokalaEmmanouil S Brilakis
Mar 31, 2004·The American Journal of Cardiology·Stephen J ServossUNKNOWN PRISM-PLUS trial
Jan 28, 2010·American Heart Journal·Esam ElbarasiUNKNOWN Canadian Global Registry of Acute Coronary Events (GRACE/expanded-GRACE) Investigators
Aug 30, 2016·European Heart Journal·Alon EisenUNKNOWN IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators
Oct 9, 2014·European Heart Journal. Acute Cardiovascular Care·Rogério TeixeiraBernard J Gersh
Apr 24, 2014·Expert Review of Cardiovascular Therapy·Rafid Fayadh Al-Aqeedi, Jassim Al Suwaidi
Nov 14, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·D Bouchard, R Cartier
Jul 29, 2021·Arquivos brasileiros de cardiologia·José Carlos NicolauWilson Mathias Júnior

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.